This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Kovac V, Dodic-Fikfak M, Arneric N, Dolzan V, Franko A. Fibulin-3 as a bio-marker of response to treatment in malignant mesothelioma. Radiol Oncol 2015; 49: 279-85. doi: 10.1515/raon-2015-0019KovacVDodic-FikfakMArnericNDolzanVFrankoAFibulin-3 as a bio-marker of response to treatment in malignant mesotheliomaRadiol Oncol2015492798510.1515/raon-2015-0019457722526401134Open DOISearch in Google Scholar
Franko A, Kotnik N, Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V. The influence of genetic variability on the risk of developing malignant mesothelioma. Radiol Oncol 2018; 52: 105-11. doi: 10.2478/raon-2018-0004FrankoAKotnikNGoricarKKovacVDodic-FikfakMDolzanVThe influence of genetic variability on the risk of developing malignant mesotheliomaRadiol Oncol2018521051110.2478/raon-2018-0004583908829520212Open DOISearch in Google Scholar
Acencio MM, Soares B, Marchi E, Silva CS, Teixeira LR, Broaddus VC. Inflammatory cytokines contribute to asbestos-induced injury of mesothelial cells. Lung 2015; 193: 831-7. doi: 10.1007/s00408-015-9744-4AcencioMMSoaresBMarchiESilvaCSTeixeiraLRBroaddusVCInflammatory cytokines contribute to asbestos-induced injury of mesothelial cellsLung2015193831710.1007/s00408-015-9744-426059286Open DOISearch in Google Scholar
Bianco A, Valente T, De Rimini ML, Sica G, Fiorelli A. Clinical diagnosis of malignant pleural mesothelioma. J Thorac Dis 2018; 10: S253-61. doi: 10.21037/jtd.2017.10.09BiancoAValenteTDe RiminiMLSicaGFiorelliAClinical diagnosis of malignant pleural mesotheliomaJ Thorac Dis201810S2536110.21037/jtd.2017.10.09583056129507793Open DOISearch in Google Scholar
Kovac V, Zwitter M, Zagar T. Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: population-based survey of 444 patients. Radiol Oncol 2012; 46: 136-44. doi: 10.2478/v10019-012-0032-0KovacVZwitterMZagarTImproved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: population-based survey of 444 patientsRadiol Oncol2012461364410.2478/v10019-012-0032-0347293823077450Open DOISearch in Google Scholar
Remon J, Lianes P, Martinez S, Velasco M, Querol R, Zanui M. Malignant mesothelioma: new insights into a rare disease. Cancer Treat Rev 2013; 39: 584-91. doi: 10.1016/j.ctrv.2012.12.005RemonJLianesPMartinezSVelascoMQuerolRZanuiMMalignant mesothelioma: new insights into a rare diseaseCancer Treat Rev2013395849110.1016/j.ctrv.2012.12.00523276688Open DOISearch in Google Scholar
Plato N, Martinsen JI, Sparen P, Hillerdal G, Weiderpass E. Occupation and mesothelioma in Sweden: updated incidence in men and women in the 27 years after the asbestos ban. Epidemiol Health 2016; 38: e2016039. doi: 10.4178/epih.e2016039PlatoNMartinsenJISparenPHillerdalGWeiderpassEOccupation and mesothelioma in Sweden: updated incidence in men and women in the 27 years after the asbestos banEpidemiol Health201638e201603910.4178/epih.e2016039511443827866405Open DOISearch in Google Scholar
Kadariya Y, Menges CW, Talarchek J, Cai KQ, Klein-Szanto AJ, Pietrofesa RA, et al. Inflammation-related IL1beta/IL1R signaling promotes the development of asbestos-induced malignant mesothelioma. Cancer Prev Res (Phila) 2016; 9: 406-14. doi: 10.1158/1940-6207.CAPR-15-0347KadariyaYMengesCWTalarchekJCaiKQKlein-SzantoAJPietrofesaRAet alInflammation-related IL1beta/IL1R signaling promotes the development of asbestos-induced malignant mesotheliomaCancer Prev Res (Phila)201694061410.1158/1940-6207.CAPR-15-0347485475326935421Open DOISearch in Google Scholar
Melaiu O, Gemignani F, Landi S. The genetic susceptibility in the development of malignant pleural mesothelioma. J Thoracic Dis 2018; 10: S246-52. doi: 10.21037/jtd.2017.10.41MelaiuOGemignaniFLandiSThe genetic susceptibility in the development of malignant pleural mesotheliomaJ Thoracic Dis201810S2465210.21037/jtd.2017.10.41583056429507792Open DOISearch in Google Scholar
Chapman SJ, Cookson WO, Musk AW, Lee YC. Benign asbestos pleural diseases. Curr Opin Pulm Med 2003; 9: 266-71. doi: 10.1097/00063198200307000-00004ChapmanSJCooksonWOMuskAWLeeYCBenign asbestos pleural diseasesCurr Opin Pulm Med200392667110.1097/00063198200307000-00004Open DOISearch in Google Scholar
Franko A, Goricar K, Kovac V, Dodic Fikfak M, Dolzan V. NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases. J Med Biochem 2019; 38: 1-10. doi: 10.2478/jomb-2019-0025FrankoAGoricarKKovacVDodic FikfakMDolzanVNLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseasesJ Med Biochem20193811010.2478/jomb-2019-0025728224232549782Open DOISearch in Google Scholar
Chew SH, Toyokuni S. Malignant mesothelioma as an oxidative stress-induced cancer: an update. Free Radic Biol Med 2015; 86: 166-78. doi: 10.1016/j.freeradbiomed.2015.05.002ChewSHToyokuniSMalignant mesothelioma as an oxidative stress-induced cancer: an updateFree Radic Biol Med2015861667810.1016/j.freeradbiomed.2015.05.00225975982Open DOISearch in Google Scholar
Hoffman HM, Wanderer AA. Inflammasome and IL-1beta-mediated disorders. Curr Allergy Asthma Rep 2010; 10: 229-35. doi: 10.1007/s11882-010-0109-zHoffmanHMWandererAAInflammasome and IL-1beta-mediated disordersCurr Allergy Asthma Rep2010102293510.1007/s11882-010-0109-z289208320425006Open DOISearch in Google Scholar
Kim YK, Shin JS, Nahm MH. NOD-Like receptors in infection, immunity, and diseases. Yonsei Med J 2016; 57: 5-14. doi: 10.3349/ymj.2016.57.1.5KimYKShinJSNahmMHNOD-Like receptors in infection, immunity, and diseasesYonsei Med J20165751410.3349/ymj.2016.57.1.5469697126632377Open DOISearch in Google Scholar
Karki R, Man SM, Kanneganti TD. Inflammasomes and cancer. Cancer Immunol Res 2017; 5: 94-9. doi: 10.1158/2326-6066.CIR-16-0269KarkiRManSMKannegantiTDInflammasomes and cancerCancer Immunol Res2017594910.1158/2326-6066.CIR-16-0269559308128093447Open DOISearch in Google Scholar
Jenko B, Praprotnik S, Tomsic M, Dolzan V. NLRP3 and CARD8 polymorphisms influence higher disease activity in rheumatoid arthritis. J Med Biochem 2016; 35: 319-23. doi: 10.1515/jomb-2016-0008JenkoBPraprotnikSTomsicMDolzanVNLRP3 and CARD8 polymorphisms influence higher disease activity in rheumatoid arthritisJ Med Biochem2016353192310.1515/jomb-2016-0008534681028356883Open DOISearch in Google Scholar
Bhat IA, Naykoo NA, Qasim I, Ganie FA, Yousuf Q, Bhat BA, et al. Association of interleukin 1 beta (IL-1beta) polymorphism with mRNA expression and risk of non small cell lung cancer. Meta Gene 2014; 2: 123-33. doi: 10.1016/j. mgene.2013.12.002BhatIANaykooNAQasimIGanieFAYousufQBhatBAet alAssociation of interleukin 1 beta (IL-1beta) polymorphism with mRNA expression and risk of non small cell lung cancerMeta Gene201421233310.1016/j.mgene.2013.12.002428780325606396Open DOISearch in Google Scholar
Hai Ping P, Feng Bo T, Li L, Nan Hui Y, Hong Z. IL-1beta/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axis. Arch Biochem Biophys 2016; 604: 20-6. doi: 10.1016/j.abb.2016.06.001Hai PingPFeng BoTLiLNan HuiYHongZIL-1beta/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axisArch Biochem Biophys201660420610.1016/j.abb.2016.06.00127264420Open DOISearch in Google Scholar
Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? RNA 2005; 11: 1753-61. doi: 10.1261/rna.2248605PillaiRSMicroRNA function: multiple mechanisms for a tiny RNA?RNA20051117536110.1261/rna.2248605137086316314451Open DOISearch in Google Scholar
Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans 2008; 36: 1211-5. doi: 10.1042/BST0361211WilliamsAEPerryMMMoschosSALarner-SvenssonHMLindsayMARole of miRNA-146a in the regulation of the innate immune response and cancerBiochem Soc Trans2008361211510.1042/BST036121119021527Open DOISearch in Google Scholar
Wang C, Zhang W, Zhang L, Chen X, Liu F, Zhang J, et al. miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2. Br J Cancer 2018; 118: e12. doi: 10.1038/bjc.2017.471WangCZhangWZhangLChenXLiuFZhangJet almiR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2Br J Cancer2018118e1210.1038/bjc.2017.471587743329462128Open DOISearch in Google Scholar
Xie YF, Shu R, Jiang SY, Liu DL, Ni J, Zhang XL. MicroRNA-146 inhibits pro-inflammatory cytokine secretion through IL-1 receptor-associated kinase 1 in human gingival fibroblasts. J Inflamm (Lond) 2013; 10: 20. doi: 10.1186/1476-9255-10-20XieYFShuRJiangSYLiuDLNiJZhangXLMicroRNA-146 inhibits pro-inflammatory cytokine secretion through IL-1 receptor-associated kinase 1 in human gingival fibroblastsJ Inflamm (Lond)2013102010.1186/1476-9255-10-20366016323680172Open DOISearch in Google Scholar
Xie W, Li Z, Li M, Xu N, Zhang Y. miR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo. Biochem Biophys Res Commun 2013; 430: 647-52. doi: 10.1016/j.bbrc.2012.11.097XieWLiZLiMXuNZhangYmiR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivoBiochem Biophys Res Commun20134306475210.1016/j.bbrc.2012.11.09723220232Open DOISearch in Google Scholar
Lo Russo G, Tessari A, Capece M, Galli G, de Braud F, Garassino MC, et al. MicroRNAs for the diagnosis and management of malignant pleural mesothelioma: a literature review. Front Oncol 2018; 8: 650. doi: 10.3389/ fonc.2018.00650LoRusso GTessariACapeceMGalliGde BraudFGarassinoMCet alMicroRNAs for the diagnosis and management of malignant pleural mesothelioma: a literature reviewFront Oncol2018865010.3389/fonc.2018.00650630814130622932Open DOISearch in Google Scholar
Ghaffarzadeh M, Ghaedi H, Alipoor B, Omrani MD, Kazerouni F, Shanaki M, et al. Association of MiR-149 (RS2292832) variant with the risk of coronary artery disease. J Med Biochem 2017; 36: 251-8. doi: 10.1515/ jomb-2017-0005GhaffarzadehMGhaediHAlipoorBOmraniMDKazerouniFShanakiMet alAssociation of MiR-149 (RS2292832) variant with the risk of coronary artery diseaseJ Med Biochem201736251810.1515/jomb-2017-0005628721930568542Open DOISearch in Google Scholar
Comer BS, Camoretti-Mercado B, Kogut PC, Halayko AJ, Solway J, Gerthoffer WT. MicroRNA-146a and microRNA-146b expression and anti-inflammatory function in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2014; 307: L727-34. doi: 10.1152/ajplung.00174.2014ComerBSCamoretti-MercadoBKogutPCHalaykoAJSolwayJGerthofferWTMicroRNA-146a and microRNA-146b expression and anti-inflammatory function in human airway smooth muscleAm J Physiol Lung Cell Mol Physiol2014307L7273410.1152/ajplung.00174.2014421700325217662Open DOISearch in Google Scholar
Ichii O, Otsuka S, Sasaki N, Namiki Y, Hashimoto Y, Kon Y. Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation. Kidney Int 2012; 81: 280-92. doi: 10.1038/ki.2011.345IchiiOOtsukaSSasakiNNamikiYHashimotoYKonYAltered expression of microRNA miR-146a correlates with the development of chronic renal inflammationKidney Int2012812809210.1038/ki.2011.34521975861Open DOISearch in Google Scholar
Eaton KD, Romine PE, Goodman GE, Thornquist MD, Barnett MJ, Petersdorf EW. Inflammatory gene polymorphisms in lung cancer susceptibility. J Thorac Oncol 2018; 13: 649-59. doi: 10.1016/j.jtho.2018.01.022EatonKDRominePEGoodmanGEThornquistMDBarnettMJPetersdorfEWInflammatory gene polymorphisms in lung cancer susceptibilityJ Thorac Oncol2018136495910.1016/j.jtho.2018.01.022597624229408308Open DOISearch in Google Scholar
Qian H, Zhang D, Bao C. Two variants of Interleukin-1B gene are associated with the decreased risk, clinical features, and better overall survival of colorectal cancer: a two-center case-control study. Aging (Albany NY) 2018; 10: 4084-92. doi: 10.18632/aging.101695QianHZhangDBaoCTwo variants of Interleukin-1B gene are associated with the decreased risk, clinical features, and better overall survival of colorectal cancer: a two-center case-control studyAging (Albany NY)20181040849210.18632/aging.101695632665330563955Open DOISearch in Google Scholar
Willems P, Claes K, Baeyens A, Vandersickel V, Werbrouck J, De Ruyck K, et al. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. Genes Chromosomes Cancer 2008; 47: 137-48. doi: 10.1002/gcc.20515WillemsPClaesKBaeyensAVandersickelVWerbrouckJDe RuyckKet alPolymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivityGenes Chromosomes Cancer2008471374810.1002/gcc.2051518000863Open DOISearch in Google Scholar
Tayel SI, Fouda EAM, Elshayeb EI, Eldakamawy ARA, El-Kousy SM. Biochemical and molecular study on interleukin-1beta gene expression and relation of single nucleotide polymorphism in promoter region with Type 2 diabetes mellitus. J Cell Biochem 2018; 119: 5343-9. doi: 10.1002/jcb.26667TayelSIFoudaEAMElshayebEIEldakamawyARAEl-KousySMBiochemical and molecular study on interleukin-1beta gene expression and relation of single nucleotide polymorphism in promoter region with Type 2 diabetes mellitusJ Cell Biochem20181195343910.1002/jcb.2666729323730Open DOISearch in Google Scholar
Wang J, Shi Y, Wang G, Dong S, Yang D, Zuo X. The association between interleukin-1 polymorphisms and their protein expression in Chinese Han patients with breast cancer. Mol Genet Genomic Med 2019; 7: e804. doi: 10.1002/mgg3.804WangJShiYWangGDongSYangDZuoXThe association between interleukin-1 polymorphisms and their protein expression in Chinese Han patients with breast cancerMol Genet Genomic Med20197e80410.1002/mgg3.804668761631297985Open DOISearch in Google Scholar
Jia Y, Zang A, Shang Y, Yang H, Song Z, Wang Z, et al. MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population. Med Oncol 2014; 31: 194. doi: 10.1007/s12032-014-0194-2JiaYZangAShangYYangHSongZWangZet alMicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese populationMed Oncol20143119410.1007/s12032-014-0194-225154761Open DOISearch in Google Scholar
Svoronos AA, Engelman DM, Slack FJ. OncomiR or tumor suppressor? The duplicity of microRNAs in cancer. Cancer Res 2016; 76: 3666-70. doi: 10.1158/0008-5472.CAN-16-0359SvoronosAAEngelmanDMSlackFJOncomiR or tumor suppressor? The duplicity of microRNAs in cancerCancer Res20167636667010.1158/0008-5472.CAN-16-0359493069027325641Open DOISearch in Google Scholar
Wei Y, Li L, Gao J. The association between two common polymorphisms (miR-146a rs2910164 and miR-196a2 rs11614913) and susceptibility to gastric cancer: a meta-analysis. Cancer Biomark 2015; 15: 235-48. doi: 10.3233/CBM-150470WeiYLiLGaoJThe association between two common polymorphisms (miR-146a rs2910164 and miR-196a2 rs11614913) and susceptibility to gastric cancer: a meta-analysisCancer Biomark2015152354810.3233/CBM-15047026406571Open DOISearch in Google Scholar
Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health 2015; 41: 5-15. doi: 10.5271/sjweh.3462WolffHVehmasTOksaPRantanenJVainioHAsbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendationsScand J Work Environ Health20154151510.5271/sjweh.346225299403Open DOISearch in Google Scholar
American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004; 170: 691-715. doi: 10.1164/rccm.200310-1436stAmerican Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestosAm J Respir Crit Care Med200417069171510.1164/rccm.200310-1436st15355871Open DOISearch in Google Scholar
Dodic Fikfak M, Kriebel D, Quinn MM, Eisen EA, Wegman DH. A case control study of lung cancer and exposure to chrysotile and amphibole at a Slovenian asbestos-cement plant. Ann Occup Hyg 2007; 51: 261-8. doi: 10.1093/annhyg/mem003Dodic FikfakMKriebelDQuinnMMEisenEAWegmanDHA case control study of lung cancer and exposure to chrysotile and amphibole at a Slovenian asbestos-cement plantAnn Occup Hyg200751261810.1093/annhyg/mem00317351264Open DOISearch in Google Scholar
Dolzan V. Genetic polymorphisms and drug metabolism. Zdrav Vestn 2007; 76 (Supll II): 5-12.DolzanVGenetic polymorphisms and drug metabolismZdrav Vestn200776Supll II512Search in Google Scholar
Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D, Bhai J, et al. Ensembl 2018. Nucleic Acids Res 2018; 46: D754-61. doi: 10.1093/nar/ gkx1098ZerbinoDRAchuthanPAkanniWAmodeMRBarrellDBhaiJet alEnsembl 2018Nucleic Acids Res201846D7546110.1093/nar/gkx1098575320629155950Open DOISearch in Google Scholar
Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 2015; 31: 3555-7. doi: 10.1093/ bioinformatics/btv402MachielaMJChanockSJLDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variantsBioinformatics2015313555710.1093/bioinformatics/btv402462674726139635Open DOISearch in Google Scholar
Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res 2015; 43: D146-52. doi: 10.1093/nar/gku1104WongNWangXmiRDB: an online resource for microRNA target prediction and functional annotationsNucleic Acids Res201543D1465210.1093/nar/gku1104438392225378301Open DOISearch in Google Scholar
Chou CH, Shrestha S, Yang CD, Chang NW, Lin YL, Liao KW, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res 2018; 46: D296-302. doi: 10.1093/nar/gkx1067ChouCHShresthaSYangCDChangNWLinYLLiaoKWet almiRTarBase update 2018: a resource for experimentally validated microRNA-target interactionsNucleic Acids Res201846D29630210.1093/nar/gkx1067575322229126174Open DOISearch in Google Scholar
Levpuscek K, Goricar K, Kovac V, Dolzan V, Franko A. The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma. Radiol Oncol 2019; 53: 206-12. doi: 10.2478/raon-2019-0016LevpuscekKGoricarKKovacVDolzanVFrankoAThe influence of genetic variability of DNA repair mechanisms on the risk of malignant mesotheliomaRadiol Oncol2019532061210.2478/raon-2019-0016657249230893058Open DOISearch in Google Scholar
Riva MA, Carnevale F, Sironi VA, De Vito G, Cesana G. Mesothelioma and asbestos, fifty years of evidence: Chris Wagner and the contribution of the Italian occupational medicine community. Med Lav 2010; 101: 409-15. PMID: 21141345RivaMACarnevaleFSironiVADe VitoGCesanaGMesothelioma and asbestos, fifty years of evidence: Chris Wagner and the contribution of the Italian occupational medicine communityMed Lav201010140915PMID: 21141345Search in Google Scholar
Muscat JE, Wynder EL. Cigarette smoking, asbestos exposure, and malignant mesothelioma. Cancer Res 1991; 51: 2263-7. PMID: 2015590MuscatJEWynderELCigarette smoking, asbestos exposure, and malignant mesotheliomaCancer Res19915122637PMID 2015590Search in Google Scholar
Case BW, Abraham JL, Meeker G, Pooley FD, Pinkerton KE. Applying definitions of “asbestos” to environmental and “low-dose” exposure levels and health effects, particularly malignant mesothelioma. J Toxicol Environ Health B Crit Rev 2011; 14: 3-39. doi: 10.1080/10937404.2011.556045CaseBWAbrahamJLMeekerGPooleyFDPinkertonKEApplying definitions of “asbestos” to environmental and “low-dose” exposure levels and health effects, particularly malignant mesotheliomaJ Toxicol Environ Health B Crit Rev20111433910.1080/10937404.2011.556045311848721534084Open DOISearch in Google Scholar
Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, et al. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 2012; 227: 44-58. doi: 10.1002/jcp.22724CarboneMLyBHDodsonRFPaganoIMorrisPTDoganUAet alMalignant mesothelioma: facts, myths, and hypothesesJ Cell Physiol2012227445810.1002/jcp.22724314320621412769Open DOISearch in Google Scholar
Hillerdal G, Henderson DW. Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health 1997; 23: 93-103. doi: 10.5271/ sjweh.186HillerdalGHendersonDWAsbestos, asbestosis, pleural plaques and lung cancerScand J Work Environ Health1997239310310.5271/sjweh.1869167232Open DOISearch in Google Scholar
Maxim LD, Niebo R, Utell MJ. Are pleural plaques an appropriate endpoint for risk analyses? Inhal Toxicol 2015; 27: 321-34. doi: 10.3109/08958378.2015.1051640MaximLDNieboRUtellMJAre pleural plaques an appropriate endpoint for risk analyses?Inhal Toxicol2015273213410.3109/08958378.2015.105164026075933Open DOISearch in Google Scholar
Forloni M, Dogra SK, Dong Y, Conte D Jr, Ou J, Zhu LJ, et al. miR-146a promotes the initiation and progression of melanoma by activating Notch signaling. Elife 2014; 3: e01460. doi: 10.7554/eLife.01460ForloniMDograSKDongYConteD JrOuJZhuLJet almiR-146a promotes the initiation and progression of melanoma by activating Notch signalingElife20143e0146010.7554/eLife.01460392763324550252Open DOISearch in Google Scholar
Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci US A 2008; 105: 7269-74. doi: 10.1073/pnas.0802682105JazdzewskiKMurrayELFranssilaKJarzabBSchoenbergDRde la ChapelleACommon SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinomaProc Natl Acad Sci US A200810572697410.1073/pnas.0802682105243823918474871Open DOISearch in Google Scholar
Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 2008; 29: 1963-6. doi: 10.1093/carcin/bgn172ShenJAmbrosoneCBDiCioccioRAOdunsiKLeleSBZhaoHA functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosisCarcinogenesis2008291963610.1093/carcin/bgn17218660546Open DOISearch in Google Scholar
Kogo R, Mimori K, Tanaka F, Komune S, Mori M. Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res 2011; 17: 4277-84. doi: 10.1158/1078-0432.CCR-10-2866KogoRMimoriKTanakaFKomuneSMoriMClinical significance of miR-146a in gastric cancer casesClin Cancer Res20111742778410.1158/1078-0432.CCR-10-286621632853Open DOISearch in Google Scholar
Zhang W, Yi X, Guo S, Shi Q, Wei C, Li X, et al. A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study. J Cell Mol Med 2014; 18: 2225-34. doi: 10.1111/jcmm.12359ZhangWYiXGuoSShiQWeiCLiXet alA single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional studyJ Cell Mol Med20141822253410.1111/jcmm.12359422455625209759Open DOISearch in Google Scholar
Wang JH, Shih KS, Wu YW, Wang AW, Yang CR. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1beta signaling in osteoarthritis fibroblast-like synoviocytes. Osteoarthritis Cartilage 2013; 21: 1987-96. doi: 10.1016/j.joca.2013.09.008WangJHShihKSWuYWWangAWYangCRHistone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1beta signaling in osteoarthritis fibroblast-like synoviocytesOsteoarthritis Cartilage20132119879610.1016/j.joca.2013.09.00824107356Open DOISearch in Google Scholar
Chen G, Umelo IA, Lv S, Teugels E, Fostier K, Kronenberger P, et al. miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One 2013; 8: e60317. doi: 10.1371/journal. pone.0060317ChenGUmeloIALvSTeugelsEFostierKKronenbergerPet almiR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cellsPLoS One20138e6031710.1371/journal.pone.0060317360858423555954Open DOISearch in Google Scholar
Yao Q, Cao Z, Tu C, Zhao Y, Liu H, Zhang S. MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. Cancer Lett 2013; 335: 219-24. doi: 10.1016/j.canlet.2013.02.031YaoQCaoZTuCZhaoYLiuHZhangSMicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2Cancer Lett20133352192410.1016/j.canlet.2013.02.03123435376Open DOISearch in Google Scholar
Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008; 3: e2557. doi: 10.1371/journal. pone.0002557WangXTangSLeSYLuRRaderJSMeyersCet alAberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growthPLoS One20083e255710.1371/journal.pone.0002557243847518596939Open DOISearch in Google Scholar
